Piramal Pharma Adds Solar Power at UK Site

Piramal Pharma Solutions plans to commission a 4.3MW solar plant at its UK Morpeth facility by Q1 2027, covering 22% of electricity needs. The initiative targets a reduction of 20,000 metric tons of CO₂ equivalent over 25 years.